Robust B-cell depletion observed with budoprutug subcutaneous formulation in healthy volunteers, supporting continued ...

MDX2003 targets CD19 and CD20 on B cells and CD3 and CD28 on T cells, enhancing antitumor activity and reducing antigen loss. The therapy's design limits cytokine release syndrome, showing improved ...

B-cell lymphoma may cause abdominal swelling, chest pressure, and bone weakening as lymphoma cells affect different organs. Treatments like chemotherapy and immunotherapy for B-cell lymphoma may ...

Allogeneic, or “off-the-shelf,” cell therapies promise something different: one donor’s cells banked and shipped on demand to ...

B cells are central to the adaptive immune response, not only through the production of antibodies but also via their crucial roles in antigen presentation and cytokine secretion. Research over recent ...

B cells are central to both protective immunity and pathogenic autoimmunity. In systemic lupus erythematosus (SLE), aberrant B cell activation leads to the production of autoreactive antibodies that ...

B cells are white blood cells that form a core part of the body's adaptive immune system, enabling it to recognize specific infections, remember them, and mount a targeted response by producing ...

B-cell lymphoma is a type of non-Hodgkin lymphoma. It’s also the most common type of lymphoma. Approximately 85% of all lymphomas in the United States are B-cell lymphomas. Non-Hodgkin lymphomas are ...

Kidney damage is a serious complication affecting individuals with lupus, an autoimmune disease where immune B cells ...

About five million people worldwide have systemic lupus erythematosus (SLE), an autoimmune disease that damages organs and tissues throughout the body, including skin, joints, kidneys, heart, and ...